NIH Diversity, Equity, and Inclusion in the Research Workforce
The National Institutes of Health administers formal programs and policies designed to expand participation across the full spectrum of the biomedical research workforce. This page covers the definition and regulatory basis of NIH's diversity, equity, and inclusion (DEI) framework, the mechanisms through which those programs operate, the scenarios where they apply, and the boundaries that distinguish mandatory requirements from discretionary initiatives. Understanding this framework matters for applicants, institutions, and policymakers engaged with federal research funding.
Definition and scope
NIH defines a diverse scientific workforce as one that includes researchers from underrepresented racial and ethnic groups, individuals with disabilities, individuals from disadvantaged socioeconomic backgrounds, and women in fields where they remain underrepresented (NIH Notice of Interest in Diversity, NOT-OD-20-031). The scope of NIH's DEI obligations derives from federal statutory authority, including the NIH Revitalization Act of 1993 (Public Law 103-43), which mandated the inclusion of women and minorities in NIH-funded clinical research. Beyond clinical research enrollment, NIH extends diversity principles to the training pipeline, grant eligibility, and institutional accountability.
The distinction between workforce diversity and research subject diversity is operationally significant. Workforce diversity addresses who conducts science — postdoctoral fellows, principal investigators, graduate students, and institutional faculty. Research subject diversity addresses who is enrolled in studies. NIH programs governing each category operate under different notice numbers, funding mechanisms, and compliance expectations. Detailed coverage of funding structures relevant to workforce training appears in the NIH Grant Types and Mechanisms resource.
How it works
NIH uses four primary mechanisms to advance workforce diversity:
-
Dedicated funding programs — The Diversity Supplement program (PA-21-071) allows active NIH grantees to request administrative supplements to support researchers from underrepresented groups, including high school students, undergraduates, graduate students, postdoctoral fellows, and faculty. The Research Supplements to Promote Diversity in Health-Related Research program operates under this authority.
-
Institutional training grants with diversity requirements — T32 institutional training grants and F31 individual fellowships targeting underrepresented scholars require sponsoring institutions to document recruitment plans and report annually on trainee demographics.
-
Loan repayment programs — NIH administers 8 loan repayment programs, including a program specifically targeting researchers from disadvantaged backgrounds (NIH Loan Repayment Programs). These programs repay up to $50,000 per year in qualified educational debt in exchange for a two-year service commitment to NIH mission-relevant research.
-
Policy mandates tied to grant review — NIH's peer review process for certain grant mechanisms includes scored review of the applicant's environment and plan for enhancing diversity. Reviewers assess whether applicant institutions have infrastructure and demonstrated commitment to supporting diverse researchers.
The NIH Peer Review Process page details how scoring criteria are applied across different application types.
Common scenarios
Diversity supplements on active awards: A principal investigator holding an R01 grant identifies a qualified undergraduate student from an underrepresented racial group and submits a supplement request. The supplement is not competitive against other applications; it is reviewed administratively by NIH program staff against criteria established in the parent notice.
F31 fellowships for underrepresented predoctoral researchers: A doctoral student from a low-income background applies for an F31 Predoctoral Fellowship to Promote Diversity in Health-Related Research. The application undergoes peer review by a standing study section and requires a sponsoring institution with an active NIH training infrastructure. The NIH Training and Fellowship Programs page provides broader context on fellowship eligibility.
Institutional training grants with demographic reporting: An R25 education grant recipient reports annually to NIH on the demographic composition of participants, disaggregated by race, ethnicity, sex, and disability status. Failure to report accurately constitutes non-compliance with terms of award.
Loan repayment for disadvantaged background researchers: A postdoctoral scientist who qualifies under NIH's definition of disadvantaged background — based on criteria including receipt of federal means-tested benefits or family income below 200 percent of the poverty line — applies for the Health Disparities Research loan repayment program.
For broader context on NIH's organizational approach to equitable research investment, the NIH Mission and Strategic Goals page outlines agency-level commitments.
Decision boundaries
Not all DEI-adjacent activities at NIH carry the same compliance weight. The following distinctions govern how institutions and applicants must respond:
Mandatory vs. voluntary participation:
- Inclusion of women and minorities in clinical research is mandatory under the NIH Revitalization Act for Phase III clinical trials. Exemptions require documented justification accepted by the NIH program officer.
- Diversity supplement requests are voluntary on the part of principal investigators but must meet eligibility criteria once submitted.
- Demographic reporting on training grants is mandatory as a term of award, not discretionary.
Eligibility definitions are fixed by notice, not by institution:
NIH establishes who qualifies as "underrepresented" through national notices (NOT-OD-20-031). Institutions may not independently redefine eligibility thresholds for federally funded programs, though they may apply more expansive definitions to institutional funds.
Scored review criteria vs. pass/fail compliance:
Some diversity elements — such as plans to enhance diversity in a T32 application — contribute to the scored review. Others — such as the inclusion of women in clinical research — function as pass/fail compliance checkpoints that precede funding decisions.
The NIH Human Subjects Research Protections page addresses how inclusion requirements interact with human subjects oversight frameworks, including Institutional Review Board obligations.
The full scope of NIH's programs, funding vehicles, and policy landscape is mapped in the NIH Authority reference index, which serves as the navigational foundation for this subject coverage.